Home / Brands / The Compounding Pharmacy of America
The Compounding Pharmacy of America Recalls
383 recalls on record · September 23, 2015 to February 21, 2018 · Drugs
Recalls by year
15
18
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone Bi-Blend 50 mg/ml + Estradiol Valerate 2.5 mg/ml Injectable, The Compounding Pharmacy of America, Knoxvill
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone Bi-Blend 15 mg/ml +Estradiol Valerate 5 mg/ml Injection, Multi-Dose Vial,Sterile, Room Temperature, The Com
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 87.5 mg Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 70 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 60 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 37.5 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 30 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 25 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 200 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 20 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 12.5 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 100 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 18 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls PGE 2 (Alprostadil) 100 mcg/ml, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls MYO-DEN (30 ml) 25 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Kno
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Morphine 40 mg/ml + Bupivacaine 16 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxv
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Morphine 40 mg/ml + Bupivacaine 8 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxvi
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Morphine 30 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls MEGA-BURN, Winning at Weight Loss Formula Injectable, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharma
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls LIPOLEAN + Ascorbic Acid 50 mg/ml Injectable, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of Am
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls LIPOLEAN Injectable, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Hydromorphone 80 mg/ml + Fentanyl 15,000 mcg/ml + Bupivacaine 30 mg/ml + Baclofen 750 mcg/ml Intrathecal Solution, The C
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Hydromorphone 80 mg/ml + Fentanyl 15,000 mcg/ml + Bupivacaine 30 mg/ml Intrathecal Solution, The Compounding Pharmacy of
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Hydromorphone 80 mg/ml + Clonidine 1,800 mcg/ml + Baclofen 730 mcg/ml Intrathecal Solution, The Compounding Pharmacy of
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Hydromorphone 70 mg/ml+Fentanyl 16,000 mcg/ml+Bupivacaine 15 mg/ml+Clonidine 1,000 mcg/ml+Baclofen 900 mcg/ml Intratheca
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Fentanyl 5,000 mcg/ml + Bupivacaine 40 mg/ml Intrathecal Solution, Sterile - Preservative Free, The Compounding Pharmacy
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Betamethasone Sodium Phosphate (10 ml) 30 mg/ml Injectable, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls B-Complex 100 mg/ml Injection, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Baclofen 2,500 mcg/ml Intrathecal Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, T
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Vitatrim Active Injectable, Multi-Dose Vial, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility